Skip to contentI
ICU Medical Inc
I
ICUIICU Medical Inc Q2 2023 · 10-Q
Revenue$549.31M$549.31M−2.1% vs Q2 2022 Net Income-$9.93M-$9.93MN/M vs Q2 2022 EPS Diluted-$0.41-$0.41N/M vs Q2 2022 Gross Profit$192,327,000+14.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ICU Medical Inc · CIK 883984 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,474,000N/M Free Cash Flowderived-$19,758,000N/M Margins · derivedGross margin35.0%+5.1 pt vs Q2 2022
Operating margin0.5%+0.5 pt vs Q2 2022
Net margin-1.8%−0.5 pt vs Q2 2022
ended Jun 30, 2023 · filed Aug 7, 2023 · 38 d after period end